1284 related articles for article (PubMed ID: 26075522)
41. Targeted protein degradation and the enzymology of degraders.
Fisher SL; Phillips AJ
Curr Opin Chem Biol; 2018 Jun; 44():47-55. PubMed ID: 29885948
[TBL] [Abstract][Full Text] [Related]
42. Progress on small-molecule proteolysis-targeting chimeras.
Huang W; Wang B; Zhang Z; Zhang C; Zeng S; Shen Z
Future Med Chem; 2019 Oct; 11(20):2715-2734. PubMed ID: 31571504
[TBL] [Abstract][Full Text] [Related]
43. A small-molecule degron with a phenylpropionic acid scaffold.
Tomoshige S; Komatsu F; Kikuchi T; Sugiyama M; Kawasaki Y; Ohgane K; Furuyama Y; Sato S; Ishikawa M; Kuramochi K
Bioorg Med Chem; 2024 Jul; 109():117789. PubMed ID: 38870716
[TBL] [Abstract][Full Text] [Related]
44. Iterative Design and Optimization of Initially Inactive Proteolysis Targeting Chimeras (PROTACs) Identify VZ185 as a Potent, Fast, and Selective von Hippel-Lindau (VHL) Based Dual Degrader Probe of BRD9 and BRD7.
Zoppi V; Hughes SJ; Maniaci C; Testa A; Gmaschitz T; Wieshofer C; Koegl M; Riching KM; Daniels DL; Spallarossa A; Ciulli A
J Med Chem; 2019 Jan; 62(2):699-726. PubMed ID: 30540463
[TBL] [Abstract][Full Text] [Related]
45. TrkC-Targeted Kinase Inhibitors And PROTACs.
Zhao B; Burgess K
Mol Pharm; 2019 Oct; 16(10):4313-4318. PubMed ID: 31512882
[TBL] [Abstract][Full Text] [Related]
46. Small-Molecule PROTACS: New Approaches to Protein Degradation.
Toure M; Crews CM
Angew Chem Int Ed Engl; 2016 Feb; 55(6):1966-73. PubMed ID: 26756721
[TBL] [Abstract][Full Text] [Related]
47. Proteasome-Independent Protein Knockdown by Small-Molecule Inhibitor for the Undruggable Lung Adenocarcinoma.
Zhou W; Sun G; Zhang Z; Zhao L; Xu L; Yuan H; Li S; Dong Z; Song Y; Fang X
J Am Chem Soc; 2019 Nov; 141(46):18492-18499. PubMed ID: 31657561
[TBL] [Abstract][Full Text] [Related]
48. Design and optimization of oestrogen receptor PROTACs based on 4-hydroxytamoxifen.
Loren G; Espuny I; Llorente A; Donoghue C; Verdaguer X; Gomis RR; Riera A
Eur J Med Chem; 2022 Dec; 243():114770. PubMed ID: 36148710
[TBL] [Abstract][Full Text] [Related]
49. Bifunctional Molecules beyond PROTACs.
Conway SJ
J Med Chem; 2020 Mar; 63(6):2802-2806. PubMed ID: 32157887
[TBL] [Abstract][Full Text] [Related]
50. PROTACs: New method to degrade transcription regulating proteins.
Hu B; Zhou Y; Sun D; Yang Y; Liu Y; Li X; Li H; Chen L
Eur J Med Chem; 2020 Dec; 207():112698. PubMed ID: 32858471
[TBL] [Abstract][Full Text] [Related]
51. HaloPROTACS: Use of Small Molecule PROTACs to Induce Degradation of HaloTag Fusion Proteins.
Buckley DL; Raina K; Darricarrere N; Hines J; Gustafson JL; Smith IE; Miah AH; Harling JD; Crews CM
ACS Chem Biol; 2015 Aug; 10(8):1831-7. PubMed ID: 26070106
[TBL] [Abstract][Full Text] [Related]
52. Regulation of receptor for activated C kinase 1 protein by the von Hippel-Lindau tumor suppressor in IGF-I-induced renal carcinoma cell invasiveness.
He X; Wang J; Messing EM; Wu G
Oncogene; 2011 Feb; 30(5):535-47. PubMed ID: 20871634
[TBL] [Abstract][Full Text] [Related]
53. Protacs for treatment of cancer.
Sakamoto KM
Pediatr Res; 2010 May; 67(5):505-8. PubMed ID: 20075761
[TBL] [Abstract][Full Text] [Related]
54. Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy.
Li X; Song Y
J Hematol Oncol; 2020 May; 13(1):50. PubMed ID: 32404196
[TBL] [Abstract][Full Text] [Related]
55. Proteolysis targeting chimeras (PROTACs) for epigenetics research.
Vogelmann A; Robaa D; Sippl W; Jung M
Curr Opin Chem Biol; 2020 Aug; 57():8-16. PubMed ID: 32146413
[TBL] [Abstract][Full Text] [Related]
56. Targeting Deubiquitinating Enzymes and Autophagy in Cancer.
Mooneyham A; Bazzaro M
Methods Mol Biol; 2017; 1513():49-59. PubMed ID: 27807830
[TBL] [Abstract][Full Text] [Related]
57. Metabolism-driven in vitro/in vivo disconnect of an oral ERɑ VHL-PROTAC.
Hayhow TG; Williamson B; Lawson M; Cureton N; Braybrooke EL; Campbell A; Carbajo RJ; Cheraghchi-Bashi A; Chiarparin E; Diène CR; Fallan C; Fisher DI; Goldberg FW; Hopcroft L; Hopcroft P; Jackson A; Kettle JG; Klinowska T; Künzel U; Lamont G; Lewis HJ; Maglennon G; Martin S; Gutierrez PM; Morrow CJ; Nikolaou M; Nissink JWM; O'Shea P; Polanski R; Schade M; Scott JS; Smith A; Weber J; Wilson J; Yang B; Crafter C
Commun Biol; 2024 May; 7(1):563. PubMed ID: 38740899
[TBL] [Abstract][Full Text] [Related]
58. Induced protein degradation of anaplastic lymphoma kinase (ALK) by proteolysis targeting chimera (PROTAC).
Kang CH; Lee DH; Lee CO; Du Ha J; Park CH; Hwang JY
Biochem Biophys Res Commun; 2018 Oct; 505(2):542-547. PubMed ID: 30274779
[TBL] [Abstract][Full Text] [Related]
59. Targeting endogenous proteins for degradation through the affinity-directed protein missile system.
Fulcher LJ; Hutchinson LD; Macartney TJ; Turnbull C; Sapkota GP
Open Biol; 2017 May; 7(5):. PubMed ID: 28490657
[TBL] [Abstract][Full Text] [Related]
60. Parallel Regulation of von Hippel-Lindau Disease by pVHL-Mediated Degradation of B-Myb and Hypoxia-Inducible Factor α.
Okumura F; Uematsu K; Byrne SD; Hirano M; Joo-Okumura A; Nishikimi A; Shuin T; Fukui Y; Nakatsukasa K; Kamura T
Mol Cell Biol; 2016 Jun; 36(12):1803-17. PubMed ID: 27090638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
